Drug intelligence / Profile preview

amitriptyline + methylcobalamin

Development stage
Unknown
Lead developer
Health N U Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

AmNurite S is an oral fixed-dose combination product developed by Health N U Therapeutics, containing the tricyclic antidepressant amitriptyline hydrochloride and the active vitamin B12 analogue methylcobalamin in a sustained-release formulation. Amitriptyline functions by inhibiting the reuptake of serotonin and norepinephrine at the synaptic cleft, which enhances descending inhibitory pain pathways in the spinal cord. Methylcobalamin acts as a cofactor for methionine synthase, playing a critical role in the methylation process required for the maintenance and regeneration of the myelin sheath. This dual-action approach is designed to provide symptomatic relief from neuropathic pain while supporting the structural repair of damaged peripheral nerves. It is typically utilized in the management of conditions such as diabetic neuropathy and postherpetic neuralgia.

Brand names
AmNurite SAmNurite 10/25AmNurite
Other names
Amitriptyline HCl and Methylcobalamin SR TabletsAmitriptyline HClMethylcobalamin
02

Targets

MOR (Mu opioid receptor)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)MTR (Methionine synthase)NET (Norepinephrine Transporter)HRH2 (Histamine H2 Receptor)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on amitriptyline + methylcobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amitriptyline + methylcobalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call